Description

Onglyza (saxagliptin) Coated Tablets 5 mg. №30

Ingredients:

Each tablet contains 5 mg of saxagliptin.

Dosage:

The recommended dose is one 5 mg tablet once daily.

Indications:

Onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Contraindications:

Do not use Onglyza in patients with a history of a serious hypersensitivity reaction to saxagliptin.

Directions:

Take Onglyza by mouth with or without food as directed by your doctor, usually once daily.

Scientific Evidence:

Onglyza (saxagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones in the body, which helps to lower blood sugar levels in patients with type 2 diabetes. Clinical studies have shown that saxagliptin, as monotherapy or in combination with other antidiabetic agents, significantly reduces hemoglobin A1c levels and improves glycemic control.

Additional Information:

Onglyza has been well-tolerated in clinical trials with a low risk of hypoglycemia. It is important to follow the prescribed dosage and monitor blood sugar levels regularly while taking this medication. Consult your healthcare provider for personalized advice on managing your diabetes with Onglyza.

Research published in the American Journal of Medicine has demonstrated the cardiovascular safety of saxagliptin, providing further support for its use in patients with diabetes at risk for cardiovascular events.